Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anecortave Acetate in Open-Angle Glaucoma
NCT00320203Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Mar 2006
- Primary completion
- Jan 2008
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of anecortave in open-angle glaucoma (OAG), sponsored by Alcon Inc.. Started Mar 2006; status: completed.
02
Drugs
anecortave
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT00320203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00320203.